Brochure for the World Drug Repositioning Congress available

World Drug repositioning congress Are you concerned with reducing the cost, time and risk of drug development whilst refilling your R&D pipeline?

Drug repositioning: As the cost and time of drug development persistently increases, drug repositioning is becoming an increasingly important strategy for large pharma and small biotech alike to successfully innovate in a more cost-effective environment.

The 2012 World Drug Repositioning Congress is Europe's only commercially orientated conference that provides key technical and strategic solutions to challenges faced when adopting drug repositioning into your R&D efforts.

The brochure has just been released and you can download it here or visit our website for full list of speakers and programme:

Leave a Reply

Your email address will not be published. Required fields are marked *